A new guidebook examines possible avenues to regulating the nonmedical use of psychedelics, including psilocybin, LSD, DMT and mescaline, encouraging policymakers to take a thoughtful, evidence-based approach to regulation—one that authors say is too often overlooked amid the “madness” of the global drug war. “Regulating risky products and behaviors is just one of those things […]
A new guidebook examines possible avenues to regulating the nonmedical use of psychedelics, including psilocybin, LSD, DMT and mescaline, encouraging policymakers to take a thoughtful, evidence-based approach to regulation—one that authors say is too often overlooked amid the “madness” of the global drug war. “Regulating risky products and behaviors is just one of those things Read More